v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Ordinary Shares/ Common Stock
Treasury Shares/ Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   163,234,542        
Beginning balance at Dec. 31, 2022 $ 1,138,900 $ 163,235 $ (49,341) $ 1,698,781 $ (25,471) $ (648,304)
Beginning balance (in shares) at Dec. 31, 2022     6,436,736      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 1,596     1,596    
Shares issued related to founders advisory fees - related party (in shares)   1,831,653        
Shares issued related to founders advisory fees - related party 0 $ 1,832   (1,832)    
Liability portion of founders advisory fees - related party reclassified to additional paid-in capital 2,618     2,618    
Shares repurchased (in shares)     12,178,454      
Shares repurchased (64,066)   $ (64,066)      
Net (loss) income 67,486         67,486
Other comprehensive income (loss) 5,761       5,761  
Ending balance (in shares) at Dec. 31, 2023   165,066,195        
Ending balance at Dec. 31, 2023 1,152,295 $ 165,067 $ (113,407) 1,701,163 (19,710) (580,818)
Ending balance (in shares) at Dec. 31, 2023     18,615,190      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 12,849     12,849    
Shares issued related to founders advisory fees - related party (in shares)   1,758,464        
Shares issued related to founders advisory fees - related party 0 $ 1,758   (1,758)    
Liability portion of founders advisory fees - related party reclassified to additional paid-in capital 8,464     8,464    
Shares repurchased (in shares)     2,988,291      
Shares repurchased (14,420)   $ (14,420)      
Warrants exercised (in shares)   2,601,455        
Warrants exercised 23,509 $ 2,601   20,908    
Change to par value common stock 0 $ (169,409)   169,409    
Net (loss) income (5,905)         (5,905)
Other comprehensive income (loss) $ (19,522)       (19,522)  
Ending balance (in shares) at Dec. 31, 2024 169,426,114 169,426,114        
Ending balance at Dec. 31, 2024 $ 1,157,270 $ 17 $ (127,827) 1,911,035 (39,232) (586,723)
Ending balance (in shares) at Dec. 31, 2024 21,603,481   21,603,481      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 16,647     16,647    
Shares issued related to founders advisory fees - related party (in shares)   1,837,304        
Liability portion of founders advisory fees - related party reclassified to additional paid-in capital 138,823     138,823    
Shares repurchased (in shares)     3,774,675      
Shares repurchased $ (40,370)   $ (40,370)      
Shares issued upon exercise of options (in shares) 3,575,439 3,554,798        
Shares issued upon exercise of options $ 34,453     34,453    
Net (loss) income (206,366)         (206,366)
Other comprehensive income (loss) $ 32,862       32,862  
Ending balance (in shares) at Dec. 31, 2025 174,818,216 174,818,216        
Ending balance at Dec. 31, 2025 $ 1,133,319 $ 17 $ (168,197) $ 2,100,958 $ (6,370) $ (793,089)
Ending balance (in shares) at Dec. 31, 2025 25,378,156   25,378,156